Page 18 - Smab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mercenaries entered our house and riddled my husband with bullets. the acting prime minster growing emotional after telling me he's spoke ton her. >> justice. for president jovenel moise. >> reporter: that's what you all want. >> that's what the first lady believes, that i can give justice to her husband. and i will not deceive moises' family. >> reporter: as the investigation continues, a political battle is looming. the acting prime minster is recognized by the u.s. and the u.n., but another man who had just been appointed to that role by president moise a day before the attack says he shoul...

They have pretty good evidence this vaccine generates antibodies even in young people, but now they have to make sure they get the dosing right. that could take some time. that's where we get to the early fall time frame. >> i can't wait. >> sanjay, the fda approved a new alzheimer's drug yesterday. there are questions about exactly how effective it is. how much of a difference will this drug really make and what can you tell us about that? >> this is a fascinating story overall in just drug development. and what i can tell you there's controversy over this drug even though it is now approved ...

Alzheimer's drug in two decades. >> which is very exciting but tempering our expectations. this isn't the silver bull let but so good to see progress there. >> dakota ring. now i know what those letters mean. >> mab. learning? from you everyday. new overnight, the biden justice department is arguing that it should be able to represent former president trump in a defamation lawsuit brought by columnist e. jean carroll. alleging that trump defamed her when he denied raping her in the '90s. in an appeals court brief, doj lawyers argue that trump was an employee of the government at the time and...

Al Maha Academy for Boys (AMAB) has received a positive visit from Undersecretary of the Ministry of Education and Higher Education, Dr. Ibrahim  Al Nuaimi. 

NEW YORK CITY (dpa-AFX) - Biopharmaceutical company Xencor, Inc. (XNCR) announced Tuesday it has entered into a technology license agreement with Bristol-Myers Squibb Co. (BMY) under which Bristol